GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (FRA:20B) » Definitions » Pre-Tax Income

Biomark Diagnostics (FRA:20B) Pre-Tax Income : €-1.06 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Biomark Diagnostics's pretax income for the three months ended in Dec. 2023 was €-0.28 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.06 Mil. Biomark Diagnostics's pretax margin was -958.62%.

During the past 10 years, Biomark Diagnostics's highest Pretax Margin was -461.98%. The lowest was -3304.55%. And the median was -1203.92%.


Biomark Diagnostics Pre-Tax Income Historical Data

The historical data trend for Biomark Diagnostics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Pre-Tax Income Chart

Biomark Diagnostics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.36 -0.79 -0.73 -1.04 -1.26

Biomark Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.27 -0.34 -0.29 -0.15 -0.28

Competitive Comparison of Biomark Diagnostics's Pre-Tax Income

For the Diagnostics & Research subindustry, Biomark Diagnostics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomark Diagnostics's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's Pre-Tax Income falls into.



Biomark Diagnostics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Biomark Diagnostics's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.182+0+-0.075+0+0
=-1.26

Biomark Diagnostics's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.265+0+-0.014+0+0.001
=-0.28

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomark Diagnostics  (FRA:20B) Pre-Tax Income Explanation

Biomark Diagnostics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.278/0.029
=-958.62%

During the past 10 years, Biomark Diagnostics's highest Pretax Margin was -461.98%. The lowest was -3304.55%. And the median was -1203.92%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomark Diagnostics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics (FRA:20B) Business Description

Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (FRA:20B) Headlines

No Headlines